KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t

Updated on: October 10,2023

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t

Updated on:October 10,2023

Silent cancers: Here's what you need to know when there are no obvious symptoms

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainThe recent revelations about the Princess of Wales'scancer diagnosishighlight a crucial aspect of cancer detec

Updated on: April 06,2024

Silent cancers: Here's what you need to know when there are no obvious symptoms

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainThe recent revelations about the Princess of Wales'scancer diagnosishighlight a crucial aspect of cancer detec

Updated on:April 06,2024

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on: March 12,2024

Scientists find 'unknown link' between lung cancer and common parasite

by University of SalfordA picture of Toxoplasma infected cells in lung tissue.The brown-stained cells are those that contain the parasite. Credit: University of SalfordToxoplasma gondii, a micros

Updated on:March 12,2024

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on: October 11,2023

Perioperative Durvalumab Plus Chemo Yields Responses, EFS Benefit in Resectable NSCLC

September 11, 2023Kyle DohertyThe addition of perioperative durvalumab to neoadjuvant chemotherapy led to a significant improvement in terms of pathological complete response and event-free survival c

Updated on:October 11,2023

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on: September 27,2024

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Updated on:September 27,2024

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t

Updated on: January 08,2024

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t

Updated on:January 08,2024

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert

Updated on: December 20,2023

AI beats human breast cancer diagnosis

by Patrick GaleyBreast scans are recommended for women above 50 who exhibit no signs of cancerA computer programme can identify breast cancer from routine scans with greater accuracy than human expert

Updated on:December 20,2023

IMNN-001 Plus Neoadjuvant Chemotherapy Improves PFS in Advanced Ovarian Cancer

September 28, 2023Chris RyanTreatment with the interleukin-12 gene-mediated immunotherapy IMNN-001 in combination with neoadjuvant platinum chemotherapy led to an improvement in progression-free survi

Updated on: October 10,2023

IMNN-001 Plus Neoadjuvant Chemotherapy Improves PFS in Advanced Ovarian Cancer

September 28, 2023Chris RyanTreatment with the interleukin-12 gene-mediated immunotherapy IMNN-001 in combination with neoadjuvant platinum chemotherapy led to an improvement in progression-free survi

Updated on:October 10,2023

New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on: October 31,2023

New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on:October 31,2023

Luspatercept Provides Frontline Alternative to ESAs For Lower-Risk MDS and Anemia

September 21, 2023Courtney FlahertyUwe Platzbecker, MD, discusses the efficacy and safety data from the COMMANDS trial that supported the approval, and the next steps planned for luspatercept’s invest

Updated on: October 11,2023

Luspatercept Provides Frontline Alternative to ESAs For Lower-Risk MDS and Anemia

September 21, 2023Courtney FlahertyUwe Platzbecker, MD, discusses the efficacy and safety data from the COMMANDS trial that supported the approval, and the next steps planned for luspatercept’s invest

Updated on:October 11,2023

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on: October 21,2024

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on:October 21,2024

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on: October 11,2023

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on:October 11,2023